Correlation Between TG Therapeutics and Apellis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both TG Therapeutics and Apellis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TG Therapeutics and Apellis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TG Therapeutics and Apellis Pharmaceuticals, you can compare the effects of market volatilities on TG Therapeutics and Apellis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TG Therapeutics with a short position of Apellis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of TG Therapeutics and Apellis Pharmaceuticals.
Diversification Opportunities for TG Therapeutics and Apellis Pharmaceuticals
-0.67 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between TGTX and Apellis is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding TG Therapeutics and Apellis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apellis Pharmaceuticals and TG Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TG Therapeutics are associated (or correlated) with Apellis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apellis Pharmaceuticals has no effect on the direction of TG Therapeutics i.e., TG Therapeutics and Apellis Pharmaceuticals go up and down completely randomly.
Pair Corralation between TG Therapeutics and Apellis Pharmaceuticals
Given the investment horizon of 90 days TG Therapeutics is expected to generate 1.23 times more return on investment than Apellis Pharmaceuticals. However, TG Therapeutics is 1.23 times more volatile than Apellis Pharmaceuticals. It trades about 0.11 of its potential returns per unit of risk. Apellis Pharmaceuticals is currently generating about -0.15 per unit of risk. If you would invest 3,253 in TG Therapeutics on December 27, 2024 and sell it today you would earn a total of 826.00 from holding TG Therapeutics or generate 25.39% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
TG Therapeutics vs. Apellis Pharmaceuticals
Performance |
Timeline |
TG Therapeutics |
Apellis Pharmaceuticals |
TG Therapeutics and Apellis Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with TG Therapeutics and Apellis Pharmaceuticals
The main advantage of trading using opposite TG Therapeutics and Apellis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TG Therapeutics position performs unexpectedly, Apellis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will offset losses from the drop in Apellis Pharmaceuticals' long position.TG Therapeutics vs. Madrigal Pharmaceuticals | TG Therapeutics vs. Terns Pharmaceuticals | TG Therapeutics vs. Hepion Pharmaceuticals | TG Therapeutics vs. Exelixis |
Apellis Pharmaceuticals vs. Akero Therapeutics | Apellis Pharmaceuticals vs. Immunovant | Apellis Pharmaceuticals vs. Madrigal Pharmaceuticals | Apellis Pharmaceuticals vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |